Oncotarget: MEK inhibitors relevant to SARS-CoV-2 infection ...Middle East

- News
Oncotarget: MEK inhibitors relevant to SARS-CoV-2 infection
The @Oncotarget authors show a drug class-effect with MEKi to stimulate NK cells, inhibit inflammatory cytokines and block host-factors for SARS-CoV-2 infection leading also to suppression of SARS-CoV-2-S pseudovirus infection of human cells

Hence then, the article about oncotarget mek inhibitors relevant to sars cov 2 infection was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Oncotarget: MEK inhibitors relevant to SARS-CoV-2 infection )

Apple Storegoogle play

Last updated :

Also on site :



Latest News